ASTH

insider transactions

Astrana Health, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Jun 10, 26

David Schmidt

Director

$0

4.5K sh

Own +14%
Grant·A
Jun 10, 26

Matthew Mazdyasni

Director

$0

4.5K sh

Own +13%
Grant·A
Jun 10, 26

Mitchell W Kitayama

Director

$0

5.0K sh

Own +18%
Grant·A
Jun 10, 26

Linda Dong

Director

$0

4.5K sh

Own +5%
Grant·A
Jun 10, 26

Weili Dai,

Director

$0

4.5K sh

Own +33%
Grant·A
Jun 10, 26

John Chiang

Director

$0

4.5K sh

Own +15%
Other·F
May 16, 26

Chandan Basho KEY

COO and CFO

$312.0K

8.2K sh · $38.26

Own -5%
Other·F
Apr 14, 26

Chandan Basho KEY

COO and CFO

$112.5K

3.9K sh · $29.07

Own -2%
Grant·A
Apr 6, 26

Thomas S. Lam

Director

$0

41.7K sh

Own +10%
Grant·A
Apr 6, 26

Kenneth T. Sim KEY

Executive Chairman

$0

100.0K sh

Own +16%
Grant·A
Apr 6, 26

Brandon Sim KEY

CEO and President

$0

201.1K sh

Own +19%
Other·F
Apr 2, 26

Chandan Basho KEY

COO and CFO

$52.4K

2.1K sh · $25.05

Own -1%
Other·F
Apr 1, 26

Dinesh M. Kumar

Chief Medical Officer

$1.4M

58.0K sh · $24.51

Own -25%
Grant·A
Apr 1, 26

Dinesh M. Kumar

Chief Medical Officer

$0

35.3K sh

Own +18%
Other·F
Mar 26, 26

Glenn Sobotka

Chief Accounting Officer

$16.1K

662 sh · $24.27

Own -5%
Other·F
Mar 5, 26

Thomas S. Lam

Director

$232.3K

9.3K sh · $25.07

Own -2%
Other·F
Mar 5, 26

Dinesh M. Kumar

Chief Medical Officer

$42.5K

1.7K sh · $25.07

Own -1%
Other·F
Mar 5, 26

Chandan Basho KEY

COO and CFO

$31.1K

1.2K sh · $25.07

Own -1%
Exercise·M
Feb 2, 26

Brandon Sim KEY

CEO and President

$0

21.3K sh

Own New
Exercise·M
Feb 2, 26

Brandon Sim KEY

CEO and President

$495.8K

21.3K sh · $23.24

Own +2%
Other·F
Jan 23, 26

Dinesh M. Kumar

Chief Medical Officer

$292.2K

10.8K sh · $27.16

Own -5%
Exercise·M
Jan 13, 26

David Schmidt

Director

$0

20.0K sh

Own New
Other·F
Jan 13, 26

David Schmidt

Director

$115.8K

4.3K sh · $27.12

Own -12%
Exercise·M
Jan 13, 26

David Schmidt

Director

$115.8K

20.0K sh · $5.79

Own +127%
Other·F
Jan 1, 26

Dinesh M. Kumar

Chief Medical Officer

$126.6K

5.1K sh · $24.81

Own -2%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 10, 2026	David Schmidt	Director	Grant A	4.5K	+14%	—	$0
Jun 10, 2026	Matthew Mazdyasni	Director	Grant A	4.5K	+13%	—	$0
Jun 10, 2026	Mitchell W Kitayama	Director	Grant A	5.0K	+18%	—	$0
Jun 10, 2026	Linda Dong	Director	Grant A	4.5K	+5%	—	$0
Jun 10, 2026	Weili Dai,	Director	Grant A	4.5K	+33%	—	$0
Jun 10, 2026	John Chiang	Director	Grant A	4.5K	+15%	—	$0
May 16, 2026	Chandan Basho KEY	COO and CFO	Other F	8.2K	-5%	$38.26	$312.0K
Apr 14, 2026	Chandan Basho KEY	COO and CFO	Other F	3.9K	-2%	$29.07	$112.5K
Apr 6, 2026	Thomas S. Lam	Director	Grant A	41.7K	+10%	—	$0
Apr 6, 2026	Kenneth T. Sim KEY	Executive Chairman	Grant A	100.0K	+16%	—	$0
Apr 6, 2026	Brandon Sim KEY	CEO and President	Grant A	201.1K	+19%	—	$0
Apr 2, 2026	Chandan Basho KEY	COO and CFO	Other F	2.1K	-1%	$25.05	$52.4K
Apr 1, 2026	Dinesh M. Kumar	Chief Medical Officer	Other F	58.0K	-25%	$24.51	$1.4M
Apr 1, 2026	Dinesh M. Kumar	Chief Medical Officer	Grant A	35.3K	+18%	—	$0
Mar 26, 2026	Glenn Sobotka	Chief Accounting Officer	Other F	662	-5%	$24.27	$16.1K
Mar 5, 2026	Thomas S. Lam	Director	Other F	9.3K	-2%	$25.07	$232.3K
Mar 5, 2026	Dinesh M. Kumar	Chief Medical Officer	Other F	1.7K	-1%	$25.07	$42.5K
Mar 5, 2026	Chandan Basho KEY	COO and CFO	Other F	1.2K	-1%	$25.07	$31.1K
Feb 2, 2026	Brandon Sim KEY	CEO and President	Exercise M	21.3K	New	—	$0
Feb 2, 2026	Brandon Sim KEY	CEO and President	Exercise M	21.3K	+2%	$23.24	$495.8K
Jan 23, 2026	Dinesh M. Kumar	Chief Medical Officer	Other F	10.8K	-5%	$27.16	$292.2K
Jan 13, 2026	David Schmidt	Director	Exercise M	20.0K	New	—	$0
Jan 13, 2026	David Schmidt	Director	Other F	4.3K	-12%	$27.12	$115.8K
Jan 13, 2026	David Schmidt	Director	Exercise M	20.0K	+127%	$5.79	$115.8K
Jan 1, 2026	Dinesh M. Kumar	Chief Medical Officer	Other F	5.1K	-2%	$24.81	$126.6K

About ASTH insider trading

This page tracks insider transactions for Astrana Health, Inc. (ASTH) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.